CLINICAL_TRIALS trial_result · 2024-02-13

Clinical Trial Update: Safety, Efficacy and PK of BIVV001 in Pediatric Patients With Hemophilia A [Phase 3]

A Phase 3 study of BIVV001 in pediatric patients with Hemophilia A has completed and posted results on safety, efficacy, and pharmacokinetics.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Bioverativ, a Sanofi company | Conditions: Hemophilia A | Phase 3 | Status: COMPLETED | Results posted: 2024-02-13